Preferred Label : doxapram;
MeSH definition : A central respiratory stimulant with a brief duration of action. (From Martindale,
The Extra Pharmocopoeia, 30th ed, p1225);
CISMeF synonym : wyeth brand of doxapram; wyeth brand of doxapram hydrochloride; genopharm brand of doxapram hydrochloride; riemser brand of doxapram hydrochloride; AHP brand of doxapram hydrochloride; antigen brand of doxapram hydrochloride;
MeSH hyponym : doxapram hydrochloride; docatone; dopram; Hydrochloride, Doxapram;
MeSH CAS label : 2-Pyrrolidinone, 1-ethyl-4-(2-(4-morpholinyl)ethyl)-3,3-diphenyl-;
MeSH Related Number : doxapram hydrochloride; 309-29-5 (Doxapram); 7081-53-0 (Doxapram hydrochloride); P5RU6UOQ5Y;
Registry Number MeSH : 309-29-5;
Related CAS MeSH : P5RU6UOQ5Y (Doxapram hydrochloride);
Wikipedia link : https://en.wikipedia.org/wiki/Doxapram;
Codes EINECS : 206-216-3;
Is substance : O;
UNII : 94F3830Q73;
InChIKey : XFDJYSQDBULQSI-UHFFFAOYSA-N;
Origin ID : D004315;
UMLS CUI : C0013084;
ATC code(s)
Allowable qualifiers
CISMeF manual mappings
Currated CISMeF NLP mapping
Pharmacological action(s)
Record concept(s)
Related MeSH Supplementary Concept(s)
Semantic type(s)
UMLS correspondences (same concept)
Validated automatic mappings to BTNT
A central respiratory stimulant with a brief duration of action. (From Martindale,
The Extra Pharmocopoeia, 30th ed, p1225)
http://www.cochrane.org/fr/CD001966
2013
United Kingdom
France
French
french abstract
review of literature
infant, newborn
infant, premature
doxapram
respiratory system agents
ventilator weaning
airway extubation
treatment outcome
---
http://www.cochrane.org/fr/CD000074
2013
France
United Kingdom
French
french abstract
review of literature
apnea
infant, premature
infant, newborn
treatment outcome
doxapram
respiratory system agents
administration, intravenous
infant, premature, diseases
---
http://www.cochrane.org/fr/CD000075
2013
United Kingdom
France
French
french abstract
review of literature
xanthine
doxapram
apnea
infant, newborn
infant, premature
methylxanthine
treatment outcome
respiratory system agents
comparative study
xanthines
---
http://www.cochrane.org/fr/CD000223
2009
false
true
false
France
United Kingdom
exacerbation of chronic obstructive bronchitis
doxapram
respiratory insufficiency
treatment outcome
Chronic obstructive airways disease exacerbated
review of literature
french abstract
pulmonary disease, chronic obstructive
---